retatrutide triple agonist gip glp-1 glucagon phase 2 obesity Retatrutide: Triple-Agonist for and Metabolic Health | Sean Garvey, PhD posted on the topic Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon
Pay in 4 interest-free payments of $5.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30





















